MR. JOHN A KANE, RN
Nursing at Stanyan St, San Francisco, CA

License number

California 493892

Personal information

See more information about JOHN A KANE at radaris.com

Name

Address

Phone

John Kane, age 38

449 Martinelli St, Watsonville, CA 95076

John Kane, age 55

45133 Lorimer Ave, Lancaster, CA 93534

John Kane, age 81

4418 N Sequoia Ave, Fresno, CA 93705

(559) 225-7955

John Kane

46240 Durango Dr, Temecula, CA 92592

(847) 363-8200

John Kane

4380 Alta Mira Dr, La Mesa, CA 91941

Organization information

See more information about JOHN A KANE at bizstanding.com

John Kane MD

400 Parnassus Ave, San Francisco, CA 94143

Industry:

Medical Doctor's Office

Medical Doctors:

Jane E. Koehler (Medical Doctor),Gina Therese Moreno-John (Medical Doctor),Pamela Munster (Director),...

Professional information

Senior Director, Managed Markets And Trade At Impax Laboratories

Position:

Senior Director, Managed Markets and Trade at Impax Laboratories

Location:

San Francisco Bay Area

Industry:

Pharmaceuticals

Work:

Impax Laboratories - Hayward Ca since Aug 2011 - Senior Director, Managed Markets and Trade Consultant Jul 2008 - Sep 2011 - Consultant Hyperion Therapeutics Sep 2007 - Jul 2008 - Sr. Director Managed Care, Distribution and Operations Tercica Sep 2005 - Aug 2007 - Director, Sales Operations and Managed Care Bone Care International Sep 2004 - Aug 2005 - Account Director Daiichi Sankyo Apr 1998 - Aug 2004 - Management Boehringer Mannheim 1994 - 1998 - Associate Manager Pricing and Contracting

Education:

Texas A&M University 1982 - 1986

John Power Kane, San Francisco CA

Specialties:

General Practice, Internal Medicine, Endocrinology, Diabetes & Metabolism, Endocrinology and Metabolism

Work:

UCSF Medical Center / Moffitt-Long Hospitals
521 Parnassus Ave, San Francisco, CA 94143

Education:

Oregon Health & Science University (1957)

John A Kane, San Francisco CA - RN (Registered Nurse)

Specialties:

Nursing (Registered Nurse), Child & Adolescent Psychiatry Nursing, Psychiatric Nursing

Address:

450 Stanyan St, San Francisco 94117
(415) 750-5676 (Phone), (415) 750-4912 (Fax)

Languages:

English

Hospitals:

450 Stanyan St, San Francisco 94117
St. Mary's Medical Center
450 Stanyan St, San Francisco 94117

Director Of Engineering At Dynatherm Medical Inc.

Location:

San Francisco Bay Area

Industry:

Medical Devices

Work:

Dynatherm Medical Inc. - Fremont, CA Jan 2003 - Jun 2012 - Director of Engineering

Case Manager At Schapiro-Thorn, Inc.

Position:

Case Manager at Schapiro-Thorn, Inc.

Location:

San Francisco Bay Area

Industry:

Law Practice

Work:

Schapiro-Thorn, Inc. - Case Manager

Dr. John P Kane, San Francisco CA - MD (Doctor of Medicine)

Specialties:

Internal Medicine

Address:

UCSF Endocrinology Practice
400 Parnassus Ave, San Francisco 94143
(415) 353-2350 (Phone)

Languages:

English, Russian

Hospitals:

UCSF Endocrinology Practice
400 Parnassus Ave, San Francisco 94143
UCSF Medical Center
505 Parnassus Ave, San Francisco 94143
UCSF Medical Center at Mount Zion
1600 Divisadero St, San Francisco 94115

Education:

Medical School
Oregon Health And Science University School Of Medicine
Graduated: 1957
Moffitt Hospital University Of Ca
Santa Clara Valley Med Center
Stanford University Hospital

John Kane

Location:

San Francisco Bay Area

Industry:

Marketing and Advertising

Treatment For Age-Related Macular Degeneration (Amd)

US Patent:

2003016, Aug 28, 2003

Filed:

Dec 6, 2002

Appl. No.:

10/313641

Inventors:

Daniel Schwartz - San Francisco CA, US
Keith Duncan - San Francisco CA, US
Kathy Bailey - San Francisco CA, US
John Kane - San Francisco CA, US
Brian Ishida - Walnut Creek CA, US

International Classification:

A61K031/58, A61K031/56, A61K031/381, A61K031/203, A61K031/192

US Classification:

514/172000, 514/178000, 514/567000, 514/559000, 514/438000, 514/570000

Abstract:

The present invention addresses the treatment of age-related macular degeneration using regulation of pathogenic mechanisms similar to atherosclerosis. In further specific embodiments, reverse cholesterol transport components, such as transporters and HDL fractions, are utilized as diagnostic and therapeutic targets for age-related macular degeneration. In a specific embodiment, the lipid content of the retinal pigment epithelium, and/or Bruch's membrane is reduced.